S100A8 and myeloproliferative disorder: With increased S100A8 expression more significantly enriched in our type 1-like CALR-mutated patients and with these patients being known to be less thrombocythemic [7], it makes us wonder if S100A8 is also actively involved in altered thrombopoiesis in CALR-mutated MPN.